Filing Details
- Accession Number:
- 0001140361-12-023480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-08 09:34:30
- Reporting Period:
- 2012-05-04
- Filing Date:
- 2012-05-08
- Accepted Time:
- 2012-05-08 09:34:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1023869 | Merilee Raines | One Idexx Drive Westbrook ME 04092 | Corporate Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-04 | 5,836 | $17.14 | 176,857 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-04 | 2,608 | $38.34 | 179,465 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-04 | 8,144 | $87.03 | 171,321 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-04 | 300 | $87.97 | 171,021 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-04 | 5,836 | $0.00 | 5,836 | $17.14 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-04 | 2,608 | $0.00 | 2,608 | $38.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-02-06 | No | 4 | M | Direct | |
| 0 | 2013-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,430 | Indirect | by Charitable Remainder Unitrust |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $86.6600 to $87.5600, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $87.7300 to $88.1950, inclusive.
- Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/06/2008) of the grant.
- Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2011) of the grant.
Billionaire Hedge Funds
